24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial

Uwe Güth; Nicolette Hoefnagels; Andreas Müller; Sämi Schär; Laurent Rosset; Mahbiz Nobahar Corke; Michael Schwitter; Andreas Jakob; Cathrin Balmelli; Cornelia Leo; Matthias Fehr; David R. Thorn; Salome Riniker; Amina Chouiter-Djebaili; Jana Musilova; Karin Ribi; Friedemann Honecker

doi:10.1016/j.breast.2026.104789

24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial

Uwe Güth
, Nicolette Hoefnagels
, Andreas Müller
, Sämi Schär
, Laurent Rosset
, Mahbiz Nobahar Corke
, Michael Schwitter
, Andreas Jakob
, Cathrin Balmelli
, Cornelia Leo
, Matthias Fehr
, David R. Thorn
, Salome Riniker
, Amina Chouiter-Djebaili
, Jana Musilova
, Karin Ribi
, Friedemann Honecker

Careum Hochschule Gesundheit

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	104789
Fachzeitschrift	The Breast
Jahrgang	88
DOIs	https://doi.org/10.1016/j.breast.2026.104789
Publikationsstatus	Veröffentlicht - 1 Aug. 2026

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.1016/j.breast.2026.104789

https://linkinghub.elsevier.com/retrieve/pii/S0960977626000998

Dieses zitieren

Güth, U., Hoefnagels, N., Müller, A., Schär, S., Rosset, L., Nobahar Corke, M., Schwitter, M., Jakob, A., Balmelli, C., Leo, C., Fehr, M., Thorn, D. R., Riniker, S., Chouiter-Djebaili, A., Musilova, J., Ribi, K., & Honecker, F. (2026). 24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial. The Breast, 88, 104789. https://doi.org/10.1016/j.breast.2026.104789

@article{62c0b257c61d4f92892e6c8bac56c2e3,

title = "24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial",

author = "Uwe G{\"u}th and Nicolette Hoefnagels and Andreas M{\"u}ller and S{\"a}mi Sch{\"a}r and Laurent Rosset and \{Nobahar Corke\}, Mahbiz and Michael Schwitter and Andreas Jakob and Cathrin Balmelli and Cornelia Leo and Matthias Fehr and Thorn, \{David R.\} and Salome Riniker and Amina Chouiter-Djebaili and Jana Musilova and Karin Ribi and Friedemann Honecker",

year = "2026",

month = aug,

day = "1",

doi = "10.1016/j.breast.2026.104789",

language = "English",

volume = "88",

pages = "104789",

journal = "The Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

}

Güth, U, Hoefnagels, N, Müller, A, Schär, S, Rosset, L, Nobahar Corke, M, Schwitter, M, Jakob, A, Balmelli, C, Leo, C, Fehr, M, Thorn, DR, Riniker, S, Chouiter-Djebaili, A, Musilova, J, Ribi, K & Honecker, F 2026, '24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial', The Breast, Jg. 88, S. 104789. https://doi.org/10.1016/j.breast.2026.104789

24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial. / Güth, Uwe; Hoefnagels, Nicolette; Müller, Andreas et al.
in: The Breast, Jahrgang 88, 01.08.2026, S. 104789.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - 24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial

AU - Güth, Uwe

AU - Hoefnagels, Nicolette

AU - Müller, Andreas

AU - Schär, Sämi

AU - Rosset, Laurent

AU - Nobahar Corke, Mahbiz

AU - Schwitter, Michael

AU - Jakob, Andreas

AU - Balmelli, Cathrin

AU - Leo, Cornelia

AU - Fehr, Matthias

AU - Thorn, David R.

AU - Riniker, Salome

AU - Chouiter-Djebaili, Amina

AU - Musilova, Jana

AU - Ribi, Karin

AU - Honecker, Friedemann

PY - 2026/8/1

Y1 - 2026/8/1

U2 - 10.1016/j.breast.2026.104789

DO - 10.1016/j.breast.2026.104789

M3 - Article

SN - 0960-9776

VL - 88

SP - 104789

JO - The Breast

JF - The Breast

ER -

Güth U, Hoefnagels N, Müller A, Schär S, Rosset L, Nobahar Corke M et al. 24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial. The Breast. 2026 Aug. 1;88:104789. doi: 10.1016/j.breast.2026.104789